Skip to main content
SpringerLink
Log in

Albumin in the Critically Ill

  • Chapter
  • First Online:
Perioperative Fluid Management

  • 946 Accesses

Abstract

Albumin continues to be one of the options for colloid resuscitation in critically ill patients despite limited evidence for its use. It does seem to have an advantage over other colloids with a better side-effect profile. With it’s ability to increase intravascular oncotic pressure and other postulated metabolic benefits, albumin is preferred by many practioners worldwide for fluid resuscitation amongst ICU patients. In some studies outcome benefits have been shown, especially in patients with sepsis and post cardiac surgery patients. Limitations of its use are associated with its availability, cost and limited side-effect profile.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bunn F, Trivedi D. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev. 2012;6:CD001319.

    Google Scholar 

  2. Schortgen F, Deye N, Brochard L, Group CS. Preferred plasma volume expanders for critically ill patients: results of an international survey. Intensive Care Med. 2004;30(12):2222–9.

    PubMed  Google Scholar 

  3. Bellomo R, Morimatsu H, Presneill J, French C, Cole L, Story D, et al. Effects of saline or albumin resuscitation on standard coagulation tests. Crit Care Resusc. 2009;11(4):250–6.

    PubMed  Google Scholar 

  4. Caironi P, Gattinoni L. The clinical use of albumin: the point of view of a specialist in intensive care. Blood Transfus. 2009;7(4):259–67.

    PubMed  PubMed Central  Google Scholar 

  5. Matejtschuk P, Dash CH, Gascoigne EW. Production of human albumin solution: a continually developing colloid. Br J Anaesth. 2000;85(6):887–95.

    CAS  PubMed  Google Scholar 

  6. Vincent JL, Russell JA, Jacob M, Martin G, Guidet B, Wernerman J, et al. Albumin administration in the acutely ill: what is new and where next? Crit Care. 2014;18(4):231.

    PubMed  PubMed Central  Google Scholar 

  7. Fanali G, di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P. Human serum albumin: from bench to bedside. Mol Aspects Med. 2012;33(3):209–90.

    CAS  PubMed  Google Scholar 

  8. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–77.

    CAS  PubMed  Google Scholar 

  9. Park SK, Shin SR, Hur M, Kim WH, Oh EA, Lee SH. The effect of early goal-directed therapy for treatment of severe sepsis or septic shock: a systemic review and meta-analysis. J Crit Care. 2017;38:115–22.

    PubMed  Google Scholar 

  10. Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Crit Care Med. 2018;46(6):997–1000.

    PubMed  Google Scholar 

  11. Cohn EJ. The properties and functions of the plasma proteins, with a consideration of the methods for their separation and purification. Chem Rev. 1941;28(2):395–417.

    CAS  Google Scholar 

  12. Curling JM, Berglof J, Lindquist LO, Eriksson S. A chromatographic procedure for the purification of human plasma albumin. Vox Sang. 1977;33(2):97–107.

    CAS  PubMed  Google Scholar 

  13. Raoufinia R, Mota A, Keyhanvar N, Safari F, Shamekhi S, Abdolalizadeh J. Overview of albumin and its purification methods. Adv Pharm Bull. 2016;6(4):495–507.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. He Y, Ning T, Xie T, Qiu Q, Zhang L, Sun Y, et al. Large-scale production of functional human serum albumin from transgenic rice seeds. Proc Natl Acad Sci U S A. 2011;108(47):19078–83.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Vincent JL, Wilkes MM, Navickis RJ. Safety of human albumin–serious adverse events reported worldwide in 1998–2000. Br J Anaesth. 2003a;91(5):625–30.

    CAS  PubMed  Google Scholar 

  16. Martensson J, Bihari S, Bannard-Smith J, Glassford NJ, Lloyd-Donald P, Cioccari L, et al. Small volume resuscitation with 20% albumin in intensive care: physiological effects: the SWIPE randomised clinical trial. Intensive Care Med. 2018;44(11):1797–806.

    CAS  PubMed  Google Scholar 

  17. Iguchi N, Kosaka J, Bertolini J, May CN, Lankadeva YR, Bellomo R. Differential effects of isotonic and hypotonic 4% albumin solution on intracranial pressure and renal perfusion and function. Crit Care Resusc. 2018;20(1):48–53.

    PubMed  Google Scholar 

  18. Albumin R. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2011;10:CD001208.

    Google Scholar 

  19. Zeng Y, Adamson RH, Curry FR, Tarbell JM. Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan-1 shedding. Am J Physiol Heart Circ Physiol. 2014;306(3):H363–72.

    CAS  PubMed  Google Scholar 

  20. Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582(13):1783–7.

    CAS  PubMed  Google Scholar 

  21. Gum ET, Swanson RA, Alano C, Liu J, Hong S, Weinstein PR, et al. Human serum albumin and its N-terminal tetrapeptide (DAHK) block oxidant-induced neuronal death. Stroke. 2004;35(2):590–5.

    CAS  PubMed  Google Scholar 

  22. Quinlan GJ, Mumby S, Martin GS, Bernard GR, Gutteridge JM, Evans TW. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med. 2004;32(3):755–9.

    CAS  PubMed  Google Scholar 

  23. Quinlan GJ, Margarson MP, Mumby S, Evans TW, Gutteridge JM. Administration of albumin to patients with sepsis syndrome: a possible beneficial role in plasma thiol repletion. Clin Sci (Lond). 1998;95(4):459–65.

    CAS  PubMed  Google Scholar 

  24. Bhonsle HS, Singh SK, Srivastava G, Boppana R, Kulkarni MJ. Albumin competitively inhibits glycation of less abundant proteins. Protein Pept Lett. 2008;15(7):663–7.

    CAS  PubMed  Google Scholar 

  25. Faure P, Tamisier R, Baguet JP, Favier A, Halimi S, Levy P, et al. Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome. Eur Respir J. 2008;31(5):1046–53.

    CAS  PubMed  Google Scholar 

  26. Bellomo R, Morimatsu H, French C, Cole L, Story D, Uchino S, et al. The effects of saline or albumin resuscitation on acid-base status and serum electrolytes. Crit Care Med. 2006;34(12):2891–7.

    CAS  PubMed  Google Scholar 

  27. Evans TW. Review article: Albumin as a drug–biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther. 2002a;16(Suppl 5):6–11.

    CAS  PubMed  Google Scholar 

  28. Rasmussen KC, Hojskov M, Johansson PI, Kridina I, Kistorp T, Salling L, et al. Impact of albumin on coagulation competence and hemorrhage during major surgery: a randomized controlled trial. Medicine (Baltimore). 2016;95(9):e2720.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Boldt J, Lenz M, Kumle B, Papsdorf M. Volume replacement strategies on intensive care units: results from a postal survey. Intensive Care Med. 1998;24(2):147–51.

    CAS  PubMed  Google Scholar 

  30. Patel A, Laffan MA, Waheed U, Brett SJ. Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ. 2014;349:g4561.

    PubMed  PubMed Central  Google Scholar 

  31. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350(22):2247–56.

    CAS  PubMed  Google Scholar 

  32. Annane D, Siami S, Jaber S, Martin C, Elatrous S, Declere AD, et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA. 2013;310(17):1809–17.

    CAS  PubMed  Google Scholar 

  33. Bihari S, Wiersema UF, Perry R, Schembri D, Bouchier T, Dixon D, et al. Efficacy and safety of 20% albumin fluid loading in healthy subjects: a comparison of four resuscitation fluids. J Appl Physiol (1985). 2019;126(6):1646–60.

    CAS  Google Scholar 

  34. Martin GS, Moss M, Wheeler AP, Mealer M, Morris JA, Bernard GR. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med. 2005;33(8):1681–7.

    CAS  PubMed  Google Scholar 

  35. Serra R, Grande R, Buffone G, Gallelli L, Caroleo S, Tropea F, et al. Albumin administration prevents the onset of pressure ulcers in intensive care unit patients. Int Wound J. 2015;12(4):432–5.

    PubMed  Google Scholar 

  36. Redelmeier DA. New thinking about postoperative hypoalbuminemia: a hypothesis of occult protein-losing enteropathy. Open Med. 2009;3(4):e215–9.

    PubMed  PubMed Central  Google Scholar 

  37. Vincent J-L, Dubois M-J, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003b;237(3):319–34.

    PubMed  PubMed Central  Google Scholar 

  38. Boldt J, Papsdorf M. Fluid management in burn patients: results from a European survey-more questions than answers. Burns. 2008;34(3):328–38.

    PubMed  Google Scholar 

  39. Navickis RJ, Greenhalgh DG, Wilkes MM. Albumin in burn shock resuscitation: a meta-analysis of controlled clinical studies. J Burn Care Res. 2016;37(3):e268–78.

    PubMed  PubMed Central  Google Scholar 

  40. Guilabert P, Usua G, Martin N, Abarca L, Barret JP, Colomina MJ. Fluid resuscitation management in patients with burns: update. Br J Anaesth. 2016;117(3):284–96.

    CAS  PubMed  Google Scholar 

  41. Eljaiek R, Heylbroeck C, Dubois MJ. Albumin administration for fluid resuscitation in burn patients: a systematic review and meta-analysis. Burns. 2017;43(1):17–24.

    PubMed  Google Scholar 

  42. Xie Y, Liu W, Zhang X, Wang L, Xu L, Xiong Y, et al. Human albumin improves long-term behavioral sequelae after subarachnoid hemorrhage through neurovascular remodeling. Crit Care Med. 2015;43(10):e440–9.

    PubMed  Google Scholar 

  43. Belayev L, Pinard E, Nallet H, Seylaz J, Liu Y, Riyamongkol P, et al. Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular responses. Stroke. 2002;33(4):1077–84.

    PubMed  Google Scholar 

  44. Horstick G, Lauterbach M, Kempf T, Bhakdi S, Heimann A, Horstick M, et al. Early albumin infusion improves global and local hemodynamics and reduces inflammatory response in hemorrhagic shock. Crit Care Med. 2002;30(4):851–5.

    CAS  PubMed  Google Scholar 

  45. Belayev L, Saul I, Busto R, Danielyan K, Vigdorchik A, Khoutorova L, et al. Albumin treatment reduces neurological deficit and protects blood-brain barrier integrity after acute intracortical hematoma in the rat. Stroke. 2005;36(2):326–31.

    CAS  PubMed  Google Scholar 

  46. Zoellner H, Hofler M, Beckmann R, Hufnagl P, Vanyek E, Bielek E, et al. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci. 1996;109(Pt 10):2571–80.

    CAS  PubMed  Google Scholar 

  47. Kim YR, van Meer MP, Mandeville JB, Tejima E, Dai G, Topalkara K, et al. fMRI of delayed albumin treatment during stroke recovery in rats: implication for fast neuronal habituation in recovering brains. J Cereb Blood Flow Metab. 2007;27(1):142–53.

    CAS  PubMed  Google Scholar 

  48. Ginsberg MD, Hill MD, Palesch YY, Ryckborst KJ, Tamariz D. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke–I: Physiological responses and safety results. Stroke. 2006;37(8):2100–6.

    PubMed  Google Scholar 

  49. Ginsberg MD, Palesch YY, Martin RH, Hill MD, Moy CS, Waldman BD, et al. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke. 2011;42(1):119–27.

    CAS  PubMed  Google Scholar 

  50. Ginsberg MD, Palesch YY, Hill MD, Martin RH, Moy CS, Barsan WG, et al. High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial. Lancet Neurol. 2013;12(11):1049–58.

    CAS  PubMed  PubMed Central  Google Scholar 

  51. Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, et al. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–90.

    PubMed  PubMed Central  Google Scholar 

  52. Van Aken HK, Kampmeier TG, Ertmer C, Westphal M. Fluid resuscitation in patients with traumatic brain injury: what is a SAFE approach? Curr Opin Anaesthesiol. 2012;25(5):563–5.

    PubMed  Google Scholar 

  53. Landis RC, Brown JR, Fitzgerald D, Likosky DS, Shore-Lesserson L, Baker RA, et al. Attenuating the systemic inflammatory response to adult cardiopulmonary bypass: a critical review of the evidence base. J Extra Corpor Technol. 2014;46(3):197–211.

    PubMed  PubMed Central  Google Scholar 

  54. Pintar T, Collard CD. The systemic inflammatory response to cardiopulmonary bypass. Anesthesiol Clin North Am. 2003;21(3):453–64.

    CAS  PubMed  Google Scholar 

  55. Hirleman E, Larson DF. Cardiopulmonary bypass and edema: physiology and pathophysiology. Perfusion. 2008;23(6):311–22.

    CAS  PubMed  Google Scholar 

  56. Moret E, Jacob MW, Ranucci M, Schramko AA. Albumin-beyond fluid replacement in cardiopulmonary bypass surgery: why, how, and when? Semin Cardiothorac Vasc Anesth. 2014;18(3):252–9.

    PubMed  Google Scholar 

  57. Oliver WC Jr, Beynen FM, Nuttall GA, Schroeder DR, Ereth MH, Dearani JA, et al. Blood loss in infants and children for open heart operations: albumin 5% versus fresh-frozen plasma in the prime. Ann Thorac Surg. 2003;75(5):1506–12.

    PubMed  Google Scholar 

  58. Russell JA, Navickis RJ, Wilkes MM. Albumin versus crystalloid for pump priming in cardiac surgery: meta-analysis of controlled trials. J Cardiothorac Vasc Anesth. 2004;18(4):429–37.

    CAS  PubMed  Google Scholar 

  59. Golab HD, Scohy TV, de Jong PL, Kissler J, Takkenberg JJ, Bogers AJ. Relevance of colloid oncotic pressure regulation during neonatal and infant cardiopulmonary bypass: a prospective randomized study. Eur J Cardiothorac Surg. 2011;39(6):886–91.

    PubMed  Google Scholar 

  60. Schramko AA, Suojaranta-Ylinen RT, Kuitunen AH, Kukkonen SI, Niemi TT. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Anesth Analg. 2009;108(1):30–6.

    CAS  PubMed  Google Scholar 

  61. Navickis RJ, Haynes GR, Wilkes MM. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials. J Thorac Cardiovasc Surg. 2012;144(1):223–30.

    CAS  PubMed  Google Scholar 

  62. Fritz HG, Brandes H, Bredle DL, Bitterlich A, Vollandt R, Specht M, et al. Post-operative hypoalbuminaemia and procalcitonin elevation for prediction of outcome in cardiopulmonary bypass surgery. Acta Anaesthesiol Scand. 2003;47(10):1276–83.

    CAS  PubMed  Google Scholar 

  63. Jiang Y, Shaw AD. Albumin supplementation as a therapeutic strategy in cardiac surgery: useful tool or expensive hobby? Anesthesiology. 2016;124(5):983–5.

    PubMed  Google Scholar 

  64. Lee EH, Kim WJ, Kim JY, Chin JH, Choi DK, Sim JY, et al. Effect of exogenous albumin on the incidence of postoperative acute kidney injury in patients undergoing off-pump coronary artery bypass surgery with a preoperative albumin level of less than 4.0 g/dl. Anesthesiology. 2016;124(5):1001–11.

    CAS  PubMed  Google Scholar 

  65. Mallat J, Meddour M, Lemyze M, Durville E, Pepy F, Temime J, et al. Effects of a rapid infusion of 20% human serum albumin solution on acid-base status and electrolytes in critically ill patients. Intensive Care Med. 2016;42(1):128–9.

    PubMed  Google Scholar 

  66. Rabin J, Meyenburg T, Lowery AV, Rouse M, Gammie JS, Herr D. Restricted albumin utilization is safe and cost effective in a cardiac surgery intensive care unit. Ann Thorac Surg. 2017;104(1):42–8.

    PubMed  Google Scholar 

  67. Nearman HS, Herman ML. Toxic effects of colloids in the intensive care unit. Crit Care Clin. 1991;7(3):713–23.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Anesthesiology, Cleveland Clinic, Cleveland, OH, USA

    Sekar S. Bhavani

  2. Department of Anesthesiology, Section on Critical Care Medicine, Wake Forest University School of Medicine, Wake Forest Baptist Health, Winston-Salem, NC, USA

    Ashish K. Khanna

  3. Outcomes Research Consortium, Cleveland, OH, USA

    Ashish K. Khanna

  4. Department of General Anesthesiology, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, USA

    Piyush Mathur

Authors
  1. Sekar S. Bhavani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ashish K. Khanna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Piyush Mathur
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sekar S. Bhavani .

Editor information

Editors and Affiliations

  1. Anesthesiology Institute, Cleveland Clinic and Cleveland Clinic, Lerner College of Medicine, Cleveland, OH, USA

    Ehab Farag

  2. Anesthesiology Institute, Cleveland Clinic and Cleveland Clinic, Lerner College of Medicine, Cleveland, OH, USA

    Andrea Kurz

  3. Anesthesiology Institute, Cleveland Clinic and Cleveland Clinic, Lerner College of Medicine, Cleveland, OH, USA

    Christopher Troianos

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bhavani, S.S., Khanna, A.K., Mathur, P. (2020). Albumin in the Critically Ill. In: Farag, E., Kurz, A., Troianos, C. (eds) Perioperative Fluid Management. Springer, Cham. https://doi.org/10.1007/978-3-030-48374-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-48374-6_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-48373-9

  • Online ISBN: 978-3-030-48374-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation